Evidence map›Paper›PMID 36426345›Full record

ArticleCureus2022

A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home.

Fabrizia Farolfi, Stefania Cavazza, Andrea Mangiagalli, Luigi Cavanna

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Fabrizia FarolfiGeneral Practice, Azienda Unità Sanitaria Locale della Romagna, Solarolo, ITA.
Stefania CavazzaInternal Medicine, Arianna Anticoagulazione Foundation, Bologna, ITA.
Andrea MangiagalliGeneral Practice, Agenzia di Tutela della Salute Città Metropolitana di Milano, Milano, ITA.
Luigi CavannaOnco-hematology, Hospital of Piacenza, Piacenza, ITA.
Metropolitana Milanese (Italy) · ITANT Foundation Italy Onlus · ITOspedaliera di Piacenza · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We present the case of a 98-year-old unvaccinated male on chronic anticoagulant therapy with dabigatran for paroxysmal atrial fibrillation (AF), who has been successfully treated for COVID-19 at home, according to one of the multidrug treatments proposed, since hospital admission was not feasible. At the very beginning of symptoms, anti-inflammatory drugs, vitamin D, and adjuvant dietary supplements (quercetin, vitamin C, zinc, and vitamin K2) were administered, followed by dexamethasone and antibiotic therapy, according to the evolving clinical conditions. Gastroprotection with omeprazole was added. Eventually, our patient fully recovered, thus suggesting that careful home assistance under strict medical supervision can be successful, even in a very old subject with comorbidities, particularly if early treatment simultaneously addressing inflammation, hypercoagulation, and viral replication is started.

Indexed as

anti-inflammatory drugscovid-19 retrodietary supplementsearly treatment responseold patients

Identifiers

PMID36426345
PMCPMC9681671
OpenAlexW4307367918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.